Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-04-30

Study Completion Date

2014-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the safety and efficacy associated with the provision of acoustic and electric sound processing to individuals who demonstrate significant residual low-frequency hearing and profound high-frequency (above 1500 Hz) sensorineural hearing loss. Delivery of acoustic-electric stimulation will be provided by the Nucleus Hybrid L24 cochlear implant system.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hybrid L24 New Enrollment Post Approval Study

NCT02379819

High Frequency Sensorineural Hearing Loss

COMPLETED NA

Nucleus Hybrid L24 Extended Duration Post Approval Study

NCT02379273

Hearing Loss

COMPLETED NA

Clinical Evaluation of the Nucleus 5 Cochlear Implant (CI) System

NCT01072409

Hearing Loss

COMPLETED NA

Hybrid Cochlear Implants in Severe to Profound Adults, Children, and Adolescents

NCT01975571

Hearing Loss, High-Frequency

COMPLETED NA

Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness

NCT02189798

Hearing Loss Partial Deafness Hearing Disorders +2 more

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sensorineural Hearing Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Surgery

Implantation with the Nucleus Hybrid L24 Cochlear Implant

Group Type EXPERIMENTAL

Nucleus Hybrid L24

Intervention Type DEVICE

Implantation with Nucleus Hybrid L24 cochlear implant

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nucleus Hybrid L24

Implantation with Nucleus Hybrid L24 cochlear implant

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Eighteen years of age or older at the time of implantation.
2. Severe to profound (a threshold average of 2000, 3000, \& 4000 Hz \> 75dB HL) sensorineural hearing loss for frequencies \> 1500 Hz. Low-frequency thresholds up to and including 500 Hz should be no poorer than 60 dB HL.
3. Consonant Nucleus Consonant (CNC) monosyllabic word recognition score (mean of two lists) between 10% and 60%, inclusive (i.e., 10% \<= score \<= 60%), in the ear to be implanted.
4. CNC word recognition score in the contralateral ear equal to, or better than, the ear to be implanted but not more than 80%.
5. English spoken as a primary language.

Exclusion Criteria

1. Duration of severe-to-profound hearing loss greater than 30 years.
2. Congenital hearing loss (for the purpose of this study, onset prior to 2 years-of-age).
3. Medical or psychological conditions that contraindicate undergoing surgery.
4. Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array.
5. Conductive overlay of 15 dB or greater at two or more frequencies, in the range 250 to 1000 Hz.
6. Hearing loss of neural or central origin.
7. Diagnosis of Auditory Neuropathy.
8. Active middle-ear infection.
9. Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure(s) and prosthetic devices.
10. Unwillingness or inability of the candidate to comply with all investigational requirements.
11. Additional handicaps that would prevent or restrict participation in the audiological evaluations.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No